Inhibikase Therapeutics, Inc.
Long
āļ—āļĩāđˆāļ­āļąāļ›āđ€āļ”āļ•:

IKT Technical Analysis 🧙

413
Inhibikase Therapeutics Inc is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Diseases and related disorders inside and outside the brain. Its pipeline product, IkT-148009, targets underlying disease mechanisms to reverse the course of Parkinson's disease and the GI complications of Parkinson's disease.

If you understand the idea,ðŸŽŊ press a thumb up! 👍 Have a question? Don't be shy to ask! ðŸĪ“ Interested to study how to analyze charts, follow me!
āļ›āļīāļ”āļāļēāļĢāđ€āļ—āļĢāļ”: āļ–āļķāļ‡āđ€āļ›āđ‰āļēāļŦāļĄāļēāļĒāļāļēāļĢāļ—āļģāļāļģāđ„āļĢ
closed the trade with the profit

āļ„āļģāļˆāļģāļāļąāļ”āļŠāļīāļ—āļ˜āļīāđŒāļ„āļ§āļēāļĄāļĢāļąāļšāļœāļīāļ”āļŠāļ­āļš

āļ‚āđ‰āļ­āļĄāļđāļĨāđāļĨāļ°āļšāļ—āļ„āļ§āļēāļĄāđ„āļĄāđˆāđ„āļ”āđ‰āļĄāļĩāļ§āļąāļ•āļ–āļļāļ›āļĢāļ°āļŠāļ‡āļ„āđŒāđ€āļžāļ·āđˆāļ­āļāđˆāļ­āđƒāļŦāđ‰āđ€āļāļīāļ”āļāļīāļˆāļāļĢāļĢāļĄāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™, āļāļēāļĢāļĨāļ‡āļ—āļļāļ™, āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒ, āļ‚āđ‰āļ­āđ€āļŠāļ™āļ­āđāļ™āļ° āļŦāļĢāļ·āļ­āļ„āļģāđāļ™āļ°āļ™āļģāļ›āļĢāļ°āđ€āļ āļ—āļ­āļ·āđˆāļ™ āđ† āļ—āļĩāđˆāđƒāļŦāđ‰āļŦāļĢāļ·āļ­āļĢāļąāļšāļĢāļ­āļ‡āđ‚āļ”āļĒ TradingView āļ­āđˆāļēāļ™āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāđƒāļ™ āļ‚āđ‰āļ­āļāļģāļŦāļ™āļ”āļāļēāļĢāđƒāļŠāđ‰āļ‡āļēāļ™